Skip to main content

Table 2 Use of diagnostics to patients with and without fever in pre- and post-RDT implementation HDSS areas

From: Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests

Characteristic

Ifakara HDSS (pre-RDT implementation area)

Rufiji HDSS (post-RDT implementation area)

P-value (site)

Ā 

n/N

%(95%CI)

n/N

%(95%CI)

Ā 

All patients tested by either RDT or microscopy

354/761

46.5 (36.3-57.1)

441/710

62.1 (50.3-72.6)

0.05

ā€‚RDT

132/761

17.4 (11.0-26.2)

309/710

43.5 (32.4-55.4)

< 0.01

ā€‚Microscopy

242/761

31.8 (28.5-35.2)

132/710

18.6 (15.8-21.7)

0.05

Correct testing: Patients with fever tested either RDT or microscopy

314/627

50.1 (38.9-61.2)

400/620

64.5 (51.8-75.5)

0.09

ā€‚RDT

123/627

19.6 (12.4-29.6)

282/620

45.5 (33.3-58.2)

< 0.01

ā€‚Microscopy

210/627

33.5 (29.8-37.3)

118/620

19.0 (16.0-22.3)

0.04

Over-testing: Patients without fever tested with either RDT or microscopy

40/134

29.9 (16.5-47.9)

41/90

45.6 (32.9-58.8)

0.15

ā€‚High season

5/60

8.3 (3.6-18.0)

26/56

46.4 (33.2-60.2)

<0.01

ā€‚Low season

35/74

47.3 (24.0-71.9)

15/34

44.1 (22.0-68.9)

0.86